Home > Insider Trading > Filing (0001104659-12-053799)

Filing Details

Accession Number:: 0001104659-12-053799
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-02 17:42:32
Reporting Period:: 2012-07-31

Filing Date:: 2012-08-02
Accepted Time:: 2012-08-02 17:42:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386858	Hyperion Therapeutics Inc	HPTX	Pharmaceutical Preparations (2834)	611512713

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1343244	P L Vii-B Partners Capital Highland	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1343673	Highland Capital Partners Vii-C Lp	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1343678	Highland Capital Partners Vii Lp	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1357840	Partnership Limited Vii Fund Entrepreneurs Highland	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1554026	Highland Management Partners Vii, Llc	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1554027	Partnership Limited Vii Partners Management Highland	C/O Highland Capital Partners One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-07-31	11,773	$0.00	11,845	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	13,346	$0.00	25,191	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	7,221	$0.00	32,412	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	3,002	$0.00	35,414	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	2,952	$0.00	38,366	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	2,084	$0.00	40,450	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2012-07-31	851	$0.00	39,599	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	33	$0.00	39,632	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	33	$0.00	39,665	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2012-07-31	1,926	$10.00	41,591	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	81,334	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	33,811	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	33,253	$0.00
Common Stock	Warrant to Purchase Common Stock	Disposition	2012-07-31	23,475	$0.00	23,475	$0.00
Series C-2 Preferred Stock	Warrant to Purchase Preferred Stock	Disposition	2012-07-31	10,077	$0.00	10,077	$0.00
Series C-2 Preferred Stock	Warrant to Purchase Preferred Stock	Disposition	2012-07-31	10,077	$0.00	10,077	$0.00
Common Stock	Series C-2 Preferred Stock	Acquisiton	2012-07-31	10,077	$0.00	382	$0.00
Common Stock	Series C-2 Preferred Stock	Acquisiton	2012-07-31	10,077	$0.00	382	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	9,695	$10.00	9,695	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	9,695	$10.00	9,695	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	382	$0.00	382	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	382	$0.00	382	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2012-07-31	11,773	$0.00	11,773	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	13,346	$0.00	13,346	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	7,221	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	3,002	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-07-31	0	$0.00	2,952	$0.00
Common Stock	Warrant to Purchase Common Stock	Disposition	2012-07-31	2,084	$0.00	2,084	$0.00
Series C-2 Preferred Stock	Warrant to Purchase Preferred Stock	Disposition	2012-07-31	894	$0.00	894	$0.00
Series C-2 Preferred Stock	Warrant to Purchase Preferred Stock	Disposition	2012-07-31	894	$0.00	894	$0.00
Common Stock	Series C-2 Preferred Stock	Acquisiton	2012-07-31	894	$0.00	894	$0.00
Common Stock	Series C-2 Preferred Stock	Acquisiton	2012-07-31	894	$0.00	894	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	861	$10.00	861	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	861	$10.00	861	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	33	$0.00	33	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2012-07-31	33	$0.00	33	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	X	Indirect
0	No	4	X	Indirect
0	No	4	X	Indirect
10,077	No	4	X	Indirect
10,077	No	4	X	Indirect
382	No	4	J	Indirect
382	No	4	J	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	X	Indirect
0	No	4	X	Indirect
0	No	4	X	Indirect
894	No	4	X	Indirect
894	No	4	X	Indirect
33	No	4	J	Indirect
33	No	4	J	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

The securities are held by Highland Capital Partners VII-C Limited Partnership ("HCP VII-C"). Highland Management Partners VII, LLC is the general partner of Highland Management Partnership VII Limited Partnership, which is the general partner of HCP VII-C. Each of Highland Management Partners VII Limited Partnership and Highland Management Partners VII, LLC disclaims beneficial ownership of all shares held by HCP VII-C except to the extent of each such entity's pecuniary interest therein.
The securities are held by Highland Entrepreneurs' Fund VII Limited Partnership ("HEF VII"). Highland Management Partners VII, LLC is the general partner of Highland Management Partnership VII Limited Partnership, which is the general partner of HEF VII. Each of Highland Management Partners VII Limited Partnership and Highland Management Partners VII, LLC disclaims beneficial ownership of all shares held by HEF VII except to the extent of each such entity's pecuniary interest therein.
Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted into one share of common stock. The convertible preferred stock had no expiration date.
Notes and accrued interest in the aggregate of $813,344 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Notes and accrued interest in the aggregate of $338,118 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Notes and accrued interest in the aggregate of $332,538 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Notes and accrued interest in the aggregate of $72,219 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Notes and accrued interest in the aggregate of $30,022 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Notes and accrued interest in the aggregate of $29,527 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
Immediately prior to the closing, the warrants automatically net exercised by their terms, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price.
Immediately prior to the closing, the warrants automatically net exercised by their terms into Series C-2 preferred stock, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price. The convertible stock had no expiration date.
These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 382 shares of the Issuer's Series C-2 preferred stock.
These shares reflect the net exercise of the common stock warrant pursuant to its terms into 1,233 shares of the Issuer's common stock.
These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 33 shares of the Issuer's Series C-2 preferred stock.